Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Reinier Timman

Biographic Data

ID7689878
NAMEReinier Timman
GIVEN NAMESReinier
FAMILY NAMETimman
SIGNATURETIMMAN R
AFFILIATIONSErasmus MC
ORCID0000-0002-7772-0394
VERIFIEDYes
TOTAL WORKS2
TOTAL CITATIONS0
WORKS AS AUTHOR2
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2012
LATEST PUBLICATION YEAR2020
H-INDEX0
  • Six and eight weeks injection frequencies of bevacizumab are non-inferior to the current four weeks injection frequency for quality of life in neovascular age-related macular degeneration

    Open Access•Martijn S Visser, Sankha Amarakoon et al.•ARTICLE•Quality of Life Research•2020

    Non-inferiority of the 6 and 8 weeks frequencies was demonstrated compared to 4 weeks on vision-related and general QoL in patients with nARMD. These results are in line with previously published results of lower frequency injections regarding visual acuity and central retinal thickness. Lower injection frequency may reduce burden, side effects, and treatment costs. In consideration of these results, 8 weeks frequency injections of intravitreal b…

  • Predicting the outcome of a cognitive-behavioral group training for patients with unexplained physical symptoms

    Open Access•Lyonne N L Zonneveld, Lyonne NL Zonneveld et al.•ARTICLE•BMC Public Health•2012

    Nederlands Trial Register, NTR1609

No prominent works on this page.

  • Predicting the outcome of a cognitive-behavioral group training for patients with unexplained physical symptoms

    Open Access•Lyonne N L Zonneveld, Lyonne NL Zonneveld et al.•ARTICLE•BMC Public Health•2012

    Nederlands Trial Register, NTR1609

  • Six and eight weeks injection frequencies of bevacizumab are non-inferior to the current four weeks injection frequency for quality of life in neovascular age-related macular degeneration

    Open Access•Martijn S Visser, Sankha Amarakoon et al.•ARTICLE•Quality of Life Research•2020

    Non-inferiority of the 6 and 8 weeks frequencies was demonstrated compared to 4 weeks on vision-related and general QoL in patients with nARMD. These results are in line with previously published results of lower frequency injections regarding visual acuity and central retinal thickness. Lower injection frequency may reduce burden, side effects, and treatment costs. In consideration of these results, 8 weeks frequency injections of intravitreal b…

Medicine (2 works) · Quality of life (healthcare (2 works) · Randomized controlled trial (2 works) · Bevacizumab (1 work) · Body Image and Dysmorphia Studies (1 work) · Chemotherapy (1 work) · Clinical Psychology (1 work) · Clinical Psychology (1 work) · Cognition (1 work) · Cognitive behavioral therapy (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae